The effects of galantamine on psychopathology in chronic stable schizophrenia. - Wikidata - awgldk - TriplyDB

The effects of galantamine on psychopathology in chronic stable schizophrenia.

The effects of galantamine on psychopathology in chronic stable schizophrenia.

http://www.wikidata.org/entity/Q33724801

about

Dipyridamole monotherapy in schizophrenia: pilot of a novel treatment approach by modulation of purinergic signaling.Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.Emerging drugs for schizophrenia.Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.

P2860

Q30438924-FF74C9D0-09FE-4A88-B6D5-43E3339B08A4 Q30487876-AB21DFD8-B5C4-4644-8871-379CE0ABAC4A Q34274859-E6655A83-03E1-42DD-B246-0FCB6871E4D7 Q37067455-DAED6062-099E-42DE-839A-89FB2F5B918F Q37874626-2C145F08-051C-47C7-A630-B3ABBFB3F6ED Q38220400-387125B5-7E32-49D3-85C7-68D5AFA5A54C Q39130393-B11B695C-DE7E-41E2-9226-8E90889BC19C

P2860

The effects of galantamine on psychopathology in chronic stable schizophrenia.

http://www.wikidata.org/entity/Q33724801

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The effects of galantamine on psychopathology in chronic stable schizophrenia.

@ast

The effects of galantamine on psychopathology in chronic stable schizophrenia.

@en

type

label

The effects of galantamine on psychopathology in chronic stable schizophrenia.

@ast

The effects of galantamine on psychopathology in chronic stable schizophrenia.

@en

prefLabel

The effects of galantamine on psychopathology in chronic stable schizophrenia.

@ast

The effects of galantamine on psychopathology in chronic stable schizophrenia.

@en

P1433

Q33724801-E0E68D3B-A0AE-4A9F-B3D6-EE82D7AF340B

P1476

Q33724801-78990CFA-8B01-4D52-B301-DFEE8C0F1010

P2093

Q33724801-1310B579-BAEE-4095-9F68-4EE1B5D9FF08

Q33724801-32274415-7B25-48C1-AAC7-038E354A2C5F

Q33724801-4E70EA9B-F6E1-4051-8600-33E11AF56FD5

Q33724801-6148B1DB-50A9-4BA5-95E9-5A309D107DAE

Q33724801-7B8F83B4-DC4F-43F8-9A5F-1BF5697D5BE9

Q33724801-80F0AB41-348A-4163-83B4-E3F2FEDE5EF9

Q33724801-EDFE77EF-4822-4F9A-A14F-04D99F0B50BA

Q33724801-FD83F1C2-0D25-43BF-910A-D2D12058B29A

P2860

Q33724801-00E838AC-0A8B-41CD-BC2F-DD7D8F5CC407

Q33724801-0A25AD43-253D-4835-8C33-EC26A898CCBE

Q33724801-127A801C-E763-4F74-99B9-482471113837

Q33724801-17B70FE6-DCC1-4C11-B984-9A40E83EA02D

Q33724801-18FC6BBF-6F39-44D9-B477-773C8F70FAA7

Q33724801-220BB5D5-B7CB-41FB-B666-4AE2A3C90661

Q33724801-245D108D-58C5-42DF-B0F5-5CE679B23EF3

Q33724801-2A9AE7E7-1511-4298-8399-4E1507E1A6AE

Q33724801-377131FE-D0CB-4FE1-BCD6-F405CA4DBEFE

Q33724801-3FB88020-173A-4D5B-BD8C-DF4CFB6E7ABF

P304

Q33724801-8D3D419B-FAE7-43B8-8361-9E77AC46A14A

P31

Q33724801-AD369418-C56C-4A72-A695-E1A4A4C3D569

P356

Q33724801-8BD4B63B-AA21-4DF2-8697-278D9FECD65A

P433

Q33724801-C42FB101-25B9-495B-980B-2C961449D5E7

P478

Q33724801-EE2C860B-4796-45ED-A9CF-E93ED7BA7EBF

P577

Q33724801-04D5ACBE-FB80-4578-8D6F-2A1F84360CC7

P698

Q33724801-D6030582-4B2D-414F-BB71-15A0EBE6F925

P921

Q33724801-0700F13E-74CF-41F5-A8B2-96C9F1522A03

P932

Q33724801-DEEBA1D4-DD64-4FEA-BD57-C2CCD85CD616

P356

WNF.0B013E31816F2795

P1433

Clinical Neuropharmacology

P1476

The effects of galantamine on psychopathology in chronic stable schizophrenia.

@en

P2093

Deanna L Kelly

http://www.w3.org/2001/XMLSchema#string

Douglas L Boggs

http://www.w3.org/2001/XMLSchema#string

Dwight Dickinson

http://www.w3.org/2001/XMLSchema#string

M Patricia Ball

http://www.w3.org/2001/XMLSchema#string

Robert P McMahon

http://www.w3.org/2001/XMLSchema#string

Robert R Conley

http://www.w3.org/2001/XMLSchema#string

Robert W Buchanan

http://www.w3.org/2001/XMLSchema#string

Stephanie Feldman

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain

Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.

Negative symptoms in schizophrenia. Definition and reliability.

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Disorganization of semantic memory underlies alogia in schizophrenia: an analysis of verbal fluency performance in Japanese subjects.

The structure of negative symptoms within schizophrenia: implications for assessment.

P304

69-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WNF.0B013E31816F2795

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18978489

http://www.w3.org/2001/XMLSchema#string

P921

P932

4049075

http://www.w3.org/2001/XMLSchema#string